Literature DB >> 20820971

Implementation science of pre-exposure prophylaxis: preparing for public use.

Kristen Underhill1, Don Operario, Matthew J Mimiaga, Margie R Skeer, Kenneth H Mayer.   

Abstract

As efficacy trials of antiretroviral pre-exposure prophylaxis (PrEP) continue, a growing literature has begun anticipating the potential challenges of implementing PrEP for HIV prevention. These efforts coincide with a shift toward combination interventions for preventing HIV, which integrate biomedical, behavioral, and structural components. The optimal implementation of PrEP would exemplify this combination model, incorporating not only PrEP drugs, but also HIV testing, safety screening, behavioral interventions addressing adherence and risk behavior, and long-term monitoring. Efforts to plan for PrEP implementation therefore present an opportunity to advance the science of implementation and delivery in HIV prevention, in order to better address the challenges of scaling up combination approaches. We review the published and unpublished literature on PrEP implementation, organizing themes into five categories: scientific groundwork, regulatory and policy groundwork, stakeholder and infrastructure groundwork, delivery, and long-term monitoring. The lessons from PrEP planning can benefit the scale-up of future combination interventions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820971      PMCID: PMC3012127          DOI: 10.1007/s11904-010-0062-4

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  37 in total

1.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

2.  Preexposure prophylaxis for HIV: unproven promise and potential pitfalls.

Authors:  Albert Y Liu; Robert M Grant; Susan P Buchbinder
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

3.  Knowledge and use of preexposure and postexposure prophylaxis among attendees of Minority Gay Pride events, 2005 through 2006.

Authors:  Andrew C Voetsch; James D Heffelfinger; Elin B Begley; Krishna Jafa-Bhushan; Patrick S Sullivan
Journal:  J Acquir Immune Defic Syndr       Date:  2007-11-01       Impact factor: 3.731

Review 4.  Pre-exposure prophylaxis for HIV infection: what if it works?

Authors:  Lynn A Paxton; Tony Hope; Harold W Jaffe
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

5.  Biomedical HIV prevention--and social science.

Authors:  John Imrie; Jonathan Elford; Susan Kippax; Graham J Hart
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

6.  Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.

Authors:  Matthew J Mimiaga; Patricia Case; Carey V Johnson; Steven A Safren; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

7.  Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback.

Authors:  N Nodin; A Carballo-Diéguez; A M Ventuneac; I C Balan; R Remien
Journal:  AIDS Care       Date:  2008-01

Review 8.  Behavioural strategies to reduce HIV transmission: how to make them work better.

Authors:  Thomas J Coates; Linda Richter; Carlos Caceres
Journal:  Lancet       Date:  2008-08-05       Impact factor: 79.321

Review 9.  Home testing for HIV infection in resource-limited settings.

Authors:  Ishani Ganguli; Ingrid V Bassett; Krista L Dong; Rochelle P Walensky
Journal:  Curr HIV/AIDS Rep       Date:  2009-11       Impact factor: 5.071

10.  The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.

Authors:  Debby C J Vissers; Hélène A C M Voeten; Nico J D Nagelkerke; J Dik F Habbema; Sake J de Vlas
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

View more
  55 in total

1.  Passing the baton: Community-based ethnography to design a randomized clinical trial on the effectiveness of oral pre-exposure prophylaxis for HIV prevention among Black men who have sex with men.

Authors:  Jonathan Garcia; Paul W Colson; Caroline Parker; Jennifer S Hirsch
Journal:  Contemp Clin Trials       Date:  2015-11-09       Impact factor: 2.226

2.  HIV-Negative Partnered Men's Willingness to Use Pre-Exposure Prophylaxis and Associated Factors Among an Internet Sample of U.S. HIV-Negative and HIV-Discordant Male Couples.

Authors:  Jason W Mitchell; Rob Stephenson
Journal:  LGBT Health       Date:  2015-02-24       Impact factor: 4.151

Review 3.  Young Black Gay/Bisexual and Other Men Who Have Sex With Men: A Review and Content Analysis of Health-Focused Research Between 1988 and 2013.

Authors:  Ryan M Wade; Gary W Harper
Journal:  Am J Mens Health       Date:  2015-09-23

4.  Intimate Partner Violence and PrEP Acceptability Among Low-Income, Young Black Women: Exploring the Mediating Role of Reproductive Coercion.

Authors:  Tiara Willie; Trace Kershaw; Jacquelyn C Campbell; Kamila A Alexander
Journal:  AIDS Behav       Date:  2017-08

5.  Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naïve men.

Authors:  S Wade Taylor; Kenneth H Mayer; Steven M Elsesser; Matthew J Mimiaga; Conall O'Cleirigh; Steven A Safren
Journal:  AIDS Behav       Date:  2014-05

Review 6.  The current status of the use of oral medication to prevent HIV transmission.

Authors:  Kenneth H Mayer; Gita Ramjee
Journal:  Curr Opin HIV AIDS       Date:  2015-07       Impact factor: 4.283

7.  Preexposure Prophylaxis Monitoring in New York City: A Public Health Approach.

Authors:  Julie E Myers; Zoe R Edelstein; Demetre C Daskalakis; Anisha D Gandhi; Kavita Misra; Alexis V Rivera; Paul M Salcuni; Kathleen Scanlin; Chi-Chi Udeagu; Sarah L Braunstein
Journal:  Am J Public Health       Date:  2018-11       Impact factor: 9.308

Review 8.  Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects.

Authors:  Larry W Chang; David Serwadda; Thomas C Quinn; Maria J Wawer; Ronald H Gray; Steven J Reynolds
Journal:  Lancet Infect Dis       Date:  2013-01       Impact factor: 25.071

Review 9.  Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine.

Authors:  E Jennifer Edelman; David A Fiellin
Journal:  Am J Prev Med       Date:  2013-01       Impact factor: 5.043

10.  Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants.

Authors:  Jonathan D Fuchs; Magdalena E Sobieszczyk; Tamra Madenwald; Doug Grove; Shelly T Karuna; Michele Andrasik; Adam Sherwat; Gail Broder; Kenneth Mayer; Beryl Koblin; Scott Hammer
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.